Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Developed by Eli Lilly, retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors a mechanism that distinguishes it from currently approved therapies such as semaglutide and tirzepatide
Inhibition of GLP-1 action resulted in a quicker gastric emptying rate and a robust glycemic effect confirmation of its action in regulating blood glucose
PLoS ONE 12:e0184764
If you are of childbearing potential, discuss appropriate contraception with your provider and consider discontinuing semaglutide at least 2 months before a planned pregnancy due to its long half-life
Switching from Tirzepatide to Semaglutide: Some people switch due to side effects like nausea or cost concerns
Insurance Clients No Insurance Self-Pay & Private Clients Why Tampa Trusts Weight & Body Solutions Serving Tampa Bay since 2007 For more than 15 years, Weight & Body Solutions has been Tampa Bays destination for weight loss, aesthetics, and wellness
US$ 20.06
US$ 29.64
US$ 26.05
US$ 20.14
US$ 29.93
